FDA Delays Decision on Moderna’s COVID-19 Vaccine for Adolescents

Published on October 15, 2021

The U.S. health regulator is delaying its decision on authorizing Moderna Inc’s COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation, the Wall Street Journal reported on Friday, citing people familiar with the matter. Moderna’s…

Read Full Article (External Site)